City

Condition

Veisalgia (2)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Sen-Jam Pharmaceutical (2)

Collaborator

Intervention

placebo (2)

fexofenadine (1)

jmi-001 (1)

jmi-001 (sjp-304 and sjp-223) (1)

naproxen (1)

sjp-223 (1)

sjp-304 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

veisalgia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Veisalgia Trial (JMI-001 (SJP-304 and SJP-223), SJP-304, SJP-223)

Completed

Veisalgia

JMI-001 (SJP-304 and SJP-223)
+3 more

(no location specified)

Jul 17, 2018

Veisalgia Trial (JMI-001, Naproxen, Fexofenadine)

Unknown status

Veisalgia

JMI-001
+3 more

(no location specified)

Jun 8, 2017